CervoMed Inc. Common Stock
CRVO
CRVO: CervoMed Inc Formerly Diffusion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. The company's product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM) and metastatic brain cancer. Geographically business activity of the firm functions through the region of the United States.
moreShow CRVO Financials
Recent trades of CRVO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by CRVO's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on CRVO's company Twitter account
Number of mentions of CRVO in WallStreetBets Daily Discussion
Recent insights relating to CRVO
Recent picks made for CRVO stock on CNBC
ETFs with the largest estimated holdings in CRVO
Flights by private jets registered to CRVO